EP4171572
DISPERSIBLE TABLET FORMULATIONS COMPRISING DOLUTEGRAVIR
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
23.6.2021:
21.5.2025:
21737779.5
:
22.6.2041:
20.9.2025
:
DISPERSIBLE TABLET FORMULATIONS COMPRISING DOLUTEGRAVIR
23.6.2021
21.5.2025
20.9.2025
:
VIIV Healthcare Company:
Corporation Service Company 251 Little Falls Drive, Wilmington, Delaware 19808, US
:
CONN, Ian Paul:
Ware Hertfordshire SG12 0DP, GB
:
DAVIES, Mark Robert:
Ware Hertfordshire SG12 0DP, GB
:
HEAFIELD, Joanne:
Ware Hertfordshire SG12 0DP, GB
:
HOLTON, Michael:
Ware Hertfordshire SG12 0DP, GB
:
MORTIMER, Neil:
Ware Hertfordshire SG12 0DP, GB
:
202009684:
25.6.2020:
GB
:
IB2021055533:
23.6.2021
:
A61K 31/5365, A61K 9/20, A61P 31/18, A61K 9/28